French Top Stock Picks from Analysts

EssilorLuxottica Société anonyme

Market Cap: €82.2b

Designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific.

Capgemini

Market Cap: €16.2b

Provides consulting, digital transformation, technology, and engineering services primarily in North America, France, the United Kingdom, Ireland, the rest of Europe, the Asia-Pacific, and Latin America.

Eurazeo

Market Cap: €2.7b

A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.

Vusion

Market Cap: €2.3b

Engages in the provision of digitalization solutions for commerce in France, rest of Europe, the Middle East, Africa, Asia, and the Americas.

Alten

Market Cap: €2.0b

Operates as an engineering and technology consultancy company in France, North America, Germany, Scandinavia, Benelux, Iberian, Italy, the United Kingdom, the Asia-Pacific, Switzerland, Eastern Europe, and internationally.

Forvia

Market Cap: €1.9b

Manufactures and sells automotive technology solutions in France, Germany, other European countries, other Europe, the Middle East, Africa, the Americas, Asia, and internationally.

Pluxee

Market Cap: €1.6b

Offers employee benefits and engagement solutions services in France, Latin America, Continental Europe, and internationally.

Nanobiotix

Market Cap: €1.5b

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Peugeot Invest Société anonyme

Market Cap: €1.5b

Operates as an investment company.

Wavestone

Market Cap: €1.0b

Provides consulting services in France and internationally.

BASSAC Société anonyme

Market Cap: €722.3m

Operates as a real estate development company primarily in France, Belgium, Germany, and Spain.

Viridien Société anonyme

Market Cap: €718.9m

Provides earth science, data science, sensing, and monitoring data, products, services, and solutions in North America, Latin America, the Central and South Americas, Europe, Africa, the Middle East, and the Asia Pacific.

Inventiva

Market Cap: €687.5m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

Kaufman & Broad

Market Cap: €471.8m

Operates as a property developer and builder in France.

Genfit

Market Cap: €439.2m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Nexity

Market Cap: €428.3m

Operates as a real estate company in Europe and internationally.

Valneva

Market Cap: €419.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Quadient

Market Cap: €416.4m

Provides digital, mail, and lockers for customers through digital and physical channels in North America, Austria, Benelux, France, Germany, Ireland, Italy, Switzerland, and the United Kingdom, and internationally.

SMCP

Market Cap: €392.7m

Operates as an apparel and accessories retail company in France and internationally.

Delta Plus Group

Market Cap: €252.2m

Engages in design, manufacture, and distribution of a range of personal protective equipment worldwide.

Aramis Group SAS

Market Cap: €248.4m

Engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Austria, Italy, and Spain.

Cellectis

Market Cap: €200.1m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Akwel

Market Cap: €183.2m

Manufactures and sells automotive and heavy goods vehicle components in Europe, the Middle East, Africa, the United States, and Asia.

Median Technologies

Market Cap: €179.4m

Engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.

Groupe Partouche

Market Cap: €173.2m

Through its subsidiaries, operates casinos, hotels, restaurants, nightclubs, leisure facilities, and bars in France, other European countries, and internationally.

Fountaine Pajot

Market Cap: €157.1m

Designs, develops, produces, and sells sailing catamarans, motor catamarans, and monohull for recreational boating markets internationally.

Innate Pharma

Market Cap: €145.4m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Sensorion

Market Cap: €143.3m

A biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France.

Rising Stone

Market Cap: €118.1m

Operates as a developer and builder of luxury and ultra-luxury real estate property in France.

Crossject Société Anonyme

Market Cap: €102.2m

Develops needle-free injection systems in France.

Lhyfe

Market Cap: €98.8m

Produces and supplies renewable green hydrogen for mobility and industry markets.

OSE Immunotherapeutics

Market Cap: €98.2m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Reworld Media Société Anonyme

Market Cap: €95.5m

Engages in the thematic media business in France.

ABIONYX Pharma

Market Cap: €94.2m

A biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States.

Carbios SAS

Market Cap: €86.9m

Engages in design and development of enzymatic processes in France.

Adocia

Market Cap: €80.8m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.